Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer

Title
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
Authors
Keywords
-
Journal
Drug Design Development and Therapy
Volume -, Issue -, Pages 117
Publisher
Dove Medical Press Ltd.
Online
2011-03-10
DOI
10.2147/dddt.s13029

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started